Quarterly report pursuant to Section 13 or 15(d)

WARRANTS (Details Narrative)

v3.23.2
WARRANTS (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended
Oct. 16, 2020
Jul. 28, 2020
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Jan. 26, 2018
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                
Debt face amount     $ 19,125,000   $ 19,125,000   $ 20,000,000  
Share-Based Payment Arrangement, Tranche One [Member]                
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                
Debt face amount   $ 20,000,000            
CFF Warrant [Member]                
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                
Warrants outstanding to purchase of common stock shares               33,334
Exercise price of warrants               $ 396.00
Investment Agreement [Member] | CFF Warrant [Member]                
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                
Warrants outstanding to purchase of common stock shares     50,207   50,207      
Exercise price of warrants     $ 283.81   $ 283.81      
Weighted average remaining life of warrants         2 years 1 month 9 days      
Warrant expire date     Jan. 26, 2025   Jan. 26, 2025      
Fair value of warrants issued         $ 6,215,225      
Loan Agreement [Member] | K2 HealthVentures LLC [Member]                
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                
Warrants to purchase shares of common stock, exercised   2,874     194,444      
Exercise price of warrants   $ 208.80            
Loan Agreement [Member] | K2 Warrant [Member]                
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                
Warrants to purchase shares of common stock, exercised   2,873            
Warrants outstanding to purchase of common stock shares   2,873            
Exercise price of warrants   $ 208.80            
Warrant expire date   Jul. 28, 2030            
Fair value of warrants issued   $ 472,409            
Loan Agreement [Member] | K2 Warrant [Member] | Maximum [Member]                
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                
Debt face amount   $ 50,000,000            
Professional Services Agreement [Member] | Warrants [Member] | Investor Relations Service Provider [Member]                
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                
Warrants outstanding to purchase of common stock shares 14,000              
Exercise price of warrants $ 32.10              
Fair value of warrants issued $ 334,740              
Warrant [Member]                
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                
Warrants to purchase shares of common stock, exercised     0 0 0 0